PharmaResearch Co., Ltd. (KOSDAQ:214450)
South Korea flag South Korea · Delayed Price · Currency is KRW
315,500
-17,500 (-5.26%)
At close: Mar 9, 2026

PharmaResearch Market Cap

PharmaResearch has a market cap or net worth of 3.28 trillion as of March 9, 2026. Its market cap has increased by 18.61% in one year.

Market Cap
3.28T
Enterprise Value
2.98T
Revenue
496.03B
Ranking
n/a
PE Ratio
21.72
Stock Price
315,500.00

Market Cap Chart

Since July 24, 2015, PharmaResearch's market cap has increased from 1.01T to 3.28T, an increase of 224.79%. That is a compound annual growth rate of 11.73%.

History

DateMarket Cap% Change
Mar 6, 20263,459.75B-17.37%
Dec 30, 20254,187.03B53.52%
Dec 30, 20242,727.28B144.17%
Dec 28, 20231,116.95B60.18%
Dec 29, 2022697.32B-14.76%
Dec 30, 2021818.02B48.15%
Dec 30, 2020 Pro Pro
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 28, 2017 Pro Pro
Dec 29, 2016 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
SK bioscience 3,431.52B
D&D Pharmatech 3,652.62B
OliX Pharmaceuticals 4,179.31B
Hugel 2,824.54B
Orum Therapeutics 2,490.56B
Voronoi 5,927.74B
Peptron 6,132.46B
Chabiotech 1,820.72B
Market Cap Rankings